Results 21 to 30 of about 15,233 (195)
Autoantibodies in post-treatment Lyme disease syndrome
Frontiers in Neurology, 2022 Armin Alaedini +3 more
doaj +3 more sources
Lyme disease and the pursuit of a clinical cure
Frontiers in Medicine, 2023 Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. Many aspects of the disease are still topics of controversy within the scientific and medical communities.
Heather Adkison, Monica E. Embers
doaj +1 more source
Life, 2022 Viral infections are a key issue in modern medicine. SARS-CoV-2 infection confirms that we are not sufficiently prepared for these unforeseen infections. The COVID-19 pandemic has cultivated a great sense of fear and distrust in patients.
Maria Lucia Sur +8 more
doaj +1 more source
Anti-Borrelia burgdorferi Antibody Profile in Post-Lyme Disease Syndrome [PDF]
Clinical and Vaccine Immunology, 2011 ABSTRACTPatients with post-Lyme disease syndrome (PLDS) report persistent symptoms of pain, fatigue, and/or concentration and memory disturbances despite antibiotic treatment for Lyme borreliosis. The etiopathogenesis of these symptoms remains unknown and no effective therapies have been identified.
Abhishek, Chandra +4 more
openaire +2 more sources
, 2016 Borrelia burgdorferi is highly susceptible to antibiotic treatment and the majority of patients profit from this treatment. Antibiotic selection, dose and route of administration, and duration of therapy for Lyme disease depend on the patient\u2019s ...
di Meo, Nicola +5 more
core +1 more source
Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation
Antibiotics, 2023 Lyme disease, the most common tick-borne disease in the United States, is caused by infection with the spirochete Borrelia burgdorferi. While most patients with acute Lyme disease recover completely if treated with antibiotics shortly after the onset of ...
Nicholas Biniaz-Harris +2 more
doaj +1 more source
Differences in clinicopathologic variables between Borrelia C6 antigen seroreactive and Borrelia C6 seronegative glomerulopathy in dogs. [PDF]
, 2019 BackgroundRapidly progressive glomerulonephritis has been described in dogs that seroreact to Borrelia burgdorferi, but no studies have compared clinicopathologic differences in Lyme-seroreactive dogs with protein-losing nephropathy (PLN) versus dogs ...
Goldstein RE +6 more
core +1 more source
Identification of New Drug Candidates Against \u3cem\u3eBorrelia burgdorferi\u3c/em\u3e Using High-Throughput Screening [PDF]
, 2016 Lyme disease is the most common zoonotic bacterial disease in North America. It is estimated that .300,000 cases per annum are reported in USA alone. A total of 10%–20% of patients who have been treated with antibiotic therapy report the recrudescence of
Babar, Mustafeez Mujtaba +9 more
core +3 more sources
Frontiers in Medicine, 2019 Introduction: The multi-system symptoms accompanying acute and post-treatment Lyme disease syndrome pose a challenge for time-limited assessment. The General Symptom Questionnaire (GSQ-30) was developed to fill the need for a brief patient-reported ...
Brian A. Fallon +14 more
doaj +1 more source
Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls [PDF]
Clinical and Vaccine Immunology, 2009 ABSTRACTIt has been reported that patients with “chronic Lyme disease” have a decreased number of natural killer cells, as defined by the CD57 marker. We performed immunophenotyping in 9 individuals with post-Lyme disease syndrome, 12 who recovered from Lyme disease, and 9 healthy volunteers.
Adriana, Marques +2 more
openaire +2 more sources